Leishmania major-infected C3H mice treated with anti-IL-12 mAb develop but do not maintain a Th2 response Thu, 11/05/2020 - 20:01 / Comments Submitted by KerstenAdmin on Thu, 11/05/2020 - 20:01 Hondowicz et al, J Immunol, November 1997 1997 Preclinical LINK
